포스콜린 시장 예측 : 공급원, 형태, 농도, 용도, 최종 사용자, 지역별 세계 분석(-2030)

According to Stratistics MRC, the Global Forskolin Market is accounted for $583.2 million in 2024 and is expected to reach $1022.05 million by 2030 growing at a CAGR of 9.8% during the forecast period. Forskolin is a natural compound derived from the root of the Coleus forskohlii plant, which belongs to the mint family. It has been traditionally used in Ayurvedic medicine for various health benefits. Forskolin is known for its ability to increase levels of cyclic AMP (cAMP) in the body, a molecule that plays a role in regulating many physiological processes, including fat breakdown, heart function, and immune response. Forskolin is commonly marketed as a weight loss supplement, though research supporting its effectiveness for this purpose is limited. It is also being investigated for potential uses in managing heart disease, asthma, and glaucoma.

According to reports, the United States is the dominant market for forskolin in North America, accounting for over 90% of the market share.

Market Dynamics:

Driver:

Increasing Demand for Natural Supplements

The rising demand for natural supplements is significantly impacting the Forskolin market. Forskolin, derived from the Coleus forskohlii plant, is increasingly sought after due to its natural weight management, anti-inflammatory, and heart health benefits. As consumers prefer plant-based and organic products, Forskolin's popularity in dietary supplements, weight loss products, and wellness solutions continues to grow. The trend towards natural health solutions, along with rising awareness of the benefits of Forskolin, is fostering market expansion, driving demand in both the retail and wellness sectors.

Restraint:

High Product Costs

High product costs are a key barrier in the Forskolin industry, limiting consumer access and reducing demand. Maintaining profit margins while keeping product prices low may be challenging for manufacturers. Furthermore, price rivalry brought on by high expenses may drive out smaller competitors. Even if forskolin products are becoming more and more well-liked in the health and wellness industry, this might restrict their potential reach and impede overall market growth, particularly in price-sensitive countries.

Opportunity:

Popularity in Fitness and Wellness

The growing popularity of fitness and wellness trends is significantly driving the Forskolin market, as it is increasingly recognized for its potential benefits in weight loss, fat reduction, and enhancing muscle mass. As consumers become more health-conscious, the demand for natural supplements like Forskolin has surged. Additionally, the rise of online health communities, fitness influencers, and wellness programs further boosts the awareness and adoption of Forskolin-based products. This trend is expected to continue, fueling market growth in the fitness and wellness sector.

Threat:

Side Effects and Safety Concerns

The Forskolin market faces hindrance due to side effects and safety concerns associated with its use. Potential side effects such as low blood pressure, increased heart rate, and digestive issues can deter consumer adoption. Additionally, the lack of sufficient regulatory oversight and inconsistent clinical evidence regarding its effectiveness and safety may raise doubts among consumers and healthcare professionals. These factors contribute to slower market growth and cautious acceptance in various regions.

Covid-19 Impact:

The COVID-19 pandemic negatively impacted the Forskolin market in Asia-Pacific, disrupting supply chains and limiting consumer spending due to economic uncertainty. However, the increased focus on health and immune support during the pandemic led to a rise in demand for natural supplements, including Forskolin. Online sales channels gained prominence, contributing to the market's gradual recovery as consumer interest in wellness and weight management grew.

The dietary supplements segment is expected to be the largest during the forecast period

The dietary supplements segment is expected to account for the largest market share during the forecast period, due to rising consumer demand for natural and effective weight management, fat burning, and overall health solutions. Forskolin's popularity in supplements, particularly for its potential to enhance metabolism, promote fat loss, and support cardiovascular health, is contributing to market growth. As consumers increasingly seek plant-based and holistic alternatives to synthetic products, the dietary supplement sector is expanding, further accelerating the demand for Forskolin in various health-related formulations.

The glaucoma segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the glaucoma segment is predicted to witness the highest growth rate due to Forskolin's potential therapeutic benefits. Research suggests that Forskolin can help reduce intraocular pressure, a key factor in glaucoma management. As a result, Forskolin is gaining attention as a natural alternative or complementary treatment for glaucoma. The growing prevalence of glaucoma, particularly in aging populations, alongside increasing interest in herbal remedies for eye health, is driving the demand for Forskolin-based solutions in the market, contributing to its expansion in the healthcare sector.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share owing to increasing popularity of dietary supplements, especially for fat loss and muscle building, supports demand for Forskolin-based products. Health-conscious consumers are increasingly opting for plant-based, natural alternatives, propelling Forskolin's use in wellness supplements. Additionally, the expanding awareness of Forskolin's potential benefits in improving heart health and managing obesity further drives its market growth in North America, particularly in the dietary and fitness supplement sectors.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR due to growing awareness of health and wellness trends. Rising disposable incomes and a shift toward healthier lifestyles further contribute to the market's growth. The expanding herbal supplement industry, supported by traditional medicine practices in countries like India and China, also fuels the demand for Forskolin-based supplements. Additionally, the popularity of Forskolin for its potential benefits in cardiovascular health and fat loss drives its market penetration in the region.

Key players in the market

Some of the key players in Forskolin market include Acumen Pharmaceuticals, Inc., Alchem International Ltd., Bio-gen Extracts Pvt. Ltd., Biosynthesis Inc., Cayman Chemical Company, Changsha Staherb Natural Ingredients Co., Ltd., ChromaDex, Inc., Hunan Nutramax Inc., Indena S.p.A., Indofine Chemical Company, Inc., LGM Pharma, LKT Laboratories, Inc, MediHerb Pty Ltd., Nutra Green Biotechnology Co., Ltd., Sabinsa Corporation, Shaanxi Green Bio-Engineering Co., Ltd., Sigma-Aldrich Corporation, TCI America and Xi'an Natural Field Bio-Technique Co., Ltd.

Key Developments:

In September 2024, Acumen Pharmaceuticals, Inc. announced that it has extended its collaboration with Lonza to enable the potential future commercial launch of sabirnetug (ACU193).

In September 2024, Cayman Chemical and Certest Pharma announced a new partnership to make Certest proprietary ionizable lipids available for LNP research through Cayman's online catalog and global network of distributors.

In November 2023, Acumen Pharmaceuticals, Inc. announced non-exclusive collaboration and license agreement with Halozyme Therapeutics Inc. The collaboration will provide Acumen access to Halozyme's ENHANZE drug delivery technology, for the development of a subcutaneous formulation of ACU193, the first clinical-stage ABO-targeting antibody.

Sources Covered:

• Natural
• Synthetic

Forms Covered:

• Powder
• Capsules/Tablets
• Liquid
• Raw Extract

Concentrations Covered:

• Low Concentration (10%)
• Medium Concentration (20% to 40%)
• High Concentration (95%)

Applications Covered:

• Allergy Treatment
• Weight Management
• Respiratory Problems
• Cardiovascular Disorders
• Glaucoma
• Hypothyroidism
• Psoriasis
• Other Applications

End Users Covered:

• Nutraceuticals
• Pharmaceutical
• Dietary Supplements
• Food Processing
• Cosmetics
• Other End Users

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

• 2.1 Abstract
• 2.2 Stake Holders
• 2.3 Research Scope
• 2.4 Research Methodology
  • 2.4.1 Data Mining
  • 2.4.2 Data Analysis
  • 2.4.3 Data Validation
  • 2.4.4 Research Approach
• 2.5 Research Sources
  • 2.5.1 Primary Research Sources
  • 2.5.2 Secondary Research Sources
  • 2.5.3 Assumptions

3 Market Trend Analysis

• 3.1 Introduction
• 3.2 Drivers
• 3.3 Restraints
• 3.4 Opportunities
• 3.5 Threats
• 3.6 Application Analysis
• 3.7 End User Analysis
• 3.8 Emerging Markets
• 3.9 Impact of Covid-19

4 Porters Five Force Analysis

• 4.1 Bargaining power of suppliers
• 4.2 Bargaining power of buyers
• 4.3 Threat of substitutes
• 4.4 Threat of new entrants
• 4.5 Competitive rivalry

5 Global Forskolin Market, By Source

• 5.1 Introduction
• 5.2 Natural
• 5.3 Synthetic

6 Global Forskolin Market, By Form

• 6.1 Introduction
• 6.2 Powder
• 6.3 Capsules/Tablets
• 6.4 Liquid
• 6.5 Raw Extract

7 Global Forskolin Market, By Concentration

• 7.1 Introduction
• 7.2 Low Concentration (10%)
• 7.3 Medium Concentration (20% to 40%)
• 7.4 High Concentration (95%)

8 Global Forskolin Market, By Application

• 8.1 Introduction
• 8.2 Allergy Treatment
• 8.3 Weight Management
• 8.4 Respiratory Problems
• 8.5 Cardiovascular Disorders
• 8.6 Glaucoma
• 8.7 Hypothyroidism
• 8.8 Psoriasis
• 8.9 Other Applications

9 Global Forskolin Market, By End User

• 9.1 Introduction
• 9.2 Nutraceuticals
• 9.3 Pharmaceutical
• 9.4 Dietary Supplements
• 9.5 Food Processing
• 9.6 Cosmetics
• 9.7 Other End Users

10 Global Forskolin Market, By Geography

• 10.1 Introduction
• 10.2 North America
  • 10.2.1 US
  • 10.2.2 Canada
  • 10.2.3 Mexico
• 10.3 Europe
  • 10.3.1 Germany
  • 10.3.2 UK
  • 10.3.3 Italy
  • 10.3.4 France
  • 10.3.5 Spain
  • 10.3.6 Rest of Europe
• 10.4 Asia Pacific
  • 10.4.1 Japan
  • 10.4.2 China
  • 10.4.3 India
  • 10.4.4 Australia
  • 10.4.5 New Zealand
  • 10.4.6 South Korea
  • 10.4.7 Rest of Asia Pacific
• 10.5 South America
  • 10.5.1 Argentina
  • 10.5.2 Brazil
  • 10.5.3 Chile
  • 10.5.4 Rest of South America
• 10.6 Middle East & Africa
  • 10.6.1 Saudi Arabia
  • 10.6.2 UAE
  • 10.6.3 Qatar
  • 10.6.4 South Africa
  • 10.6.5 Rest of Middle East & Africa

11 Key Developments

• 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
• 11.2 Acquisitions & Mergers
• 11.3 New Product Launch
• 11.4 Expansions
• 11.5 Other Key Strategies

12 Company Profiling

• 12.1 Acumen Pharmaceuticals, Inc.
• 12.2 Alchem International Ltd.
• 12.3 Bio-gen Extracts Pvt. Ltd.
• 12.4 Biosynthesis Inc.
• 12.5 Cayman Chemical Company
• 12.6 Changsha Staherb Natural Ingredients Co., Ltd.
• 12.7 ChromaDex, Inc.
• 12.8 Hunan Nutramax Inc.
• 12.9 Indena S.p.A.
• 12.10 Indofine Chemical Company, Inc.
• 12.11 LGM Pharma
• 12.12 LKT Laboratories, Inc.
• 12.13 MediHerb Pty Ltd.
• 12.14 Nutra Green Biotechnology Co., Ltd.
• 12.15 Sabinsa Corporation
• 12.16 Shaanxi Green Bio-Engineering Co., Ltd.
• 12.17 Sigma-Aldrich Corporation
• 12.18 TCI America
• 12.19 Xi'an Natural Field Bio-Technique Co., Ltd.